149 related articles for article (PubMed ID: 21239164)
1. Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-points.
Wason JM; Mander AP; Eisen TG
Eur J Cancer; 2011 May; 47(7):983-9. PubMed ID: 21239164
[TBL] [Abstract][Full Text] [Related]
2. Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
Karrison TG; Maitland ML; Stadler WM; Ratain MJ
J Natl Cancer Inst; 2007 Oct; 99(19):1455-61. PubMed ID: 17895472
[TBL] [Abstract][Full Text] [Related]
3. Optimising the design of phase II oncology trials: the importance of randomisation.
Ratain MJ; Sargent DJ
Eur J Cancer; 2009 Jan; 45(2):275-80. PubMed ID: 19059773
[TBL] [Abstract][Full Text] [Related]
4. Optimal adaptive two-stage designs for phase II cancer clinical trials.
Englert S; Kieser M
Biom J; 2013 Nov; 55(6):955-68. PubMed ID: 23868324
[TBL] [Abstract][Full Text] [Related]
5. Comparison of error rates in single-arm versus randomized phase II cancer clinical trials.
Tang H; Foster NR; Grothey A; Ansell SM; Goldberg RM; Sargent DJ
J Clin Oncol; 2010 Apr; 28(11):1936-41. PubMed ID: 20212253
[TBL] [Abstract][Full Text] [Related]
6. Effect of a misspecification of response rates on type I and type II errors, in a phase II Simon design.
Baey C; Le Deley MC
Eur J Cancer; 2011 Jul; 47(11):1647-52. PubMed ID: 21493059
[TBL] [Abstract][Full Text] [Related]
7. Comparing an experimental agent to a standard agent: relative merits of a one-arm or randomized two-arm Phase II design.
Taylor JM; Braun TM; Li Z
Clin Trials; 2006; 3(4):335-48. PubMed ID: 17060208
[TBL] [Abstract][Full Text] [Related]
8. Performance of adaptive designs for single-armed phase II oncology trials.
Kieser M; Englert S
J Biopharm Stat; 2015; 25(3):602-15. PubMed ID: 24905363
[TBL] [Abstract][Full Text] [Related]
9. Adaptive two-stage designs in phase II clinical trials.
Banerjee A; Tsiatis AA
Stat Med; 2006 Oct; 25(19):3382-95. PubMed ID: 16479547
[TBL] [Abstract][Full Text] [Related]
10. Early selection in a randomized phase II clinical trial.
Steinberg SM; Venzon DJ
Stat Med; 2002 Jun; 21(12):1711-26. PubMed ID: 12111907
[TBL] [Abstract][Full Text] [Related]
11. Optimal two-stage randomized phase II clinical trials.
Logan BR
Clin Trials; 2005; 2(1):5-12. PubMed ID: 16279574
[TBL] [Abstract][Full Text] [Related]
12. Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials.
Jung SH
Contemp Clin Trials; 2015 May; 42():9-17. PubMed ID: 25749311
[TBL] [Abstract][Full Text] [Related]
13. Operating characteristics of a Simon two-stage phase II clinical trial design incorporating continuous toxicity monitoring.
Ray HE; Rai SN
Pharm Stat; 2012; 11(2):170-6. PubMed ID: 22232063
[TBL] [Abstract][Full Text] [Related]
14. A flexible multi-stage design for phase II oncology trials.
Tan MT; Xiong X
Pharm Stat; 2011; 10(4):369-73. PubMed ID: 22328328
[TBL] [Abstract][Full Text] [Related]
15. Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials.
Pond GR; Abbasi S
Clin Trials; 2011 Jun; 8(3):260-9. PubMed ID: 21511687
[TBL] [Abstract][Full Text] [Related]
16. Sample size tables for exact single-stage phase II designs.
A'Hern RP
Stat Med; 2001 Mar; 20(6):859-66. PubMed ID: 11252008
[TBL] [Abstract][Full Text] [Related]
17. Exact two-stage designs for phase II activity trials with rank-based endpoints.
Wilding GE; Shan G; Hutson AD
Contemp Clin Trials; 2012 Mar; 33(2):332-41. PubMed ID: 22074983
[TBL] [Abstract][Full Text] [Related]
18. Curtailed two-stage designs with two dependent binary endpoints.
Chen CM; Chi Y
Pharm Stat; 2012; 11(1):57-62. PubMed ID: 22162348
[TBL] [Abstract][Full Text] [Related]
19. Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group.
Stone AM; Bushnell W; Denne J; Sargent DJ; Amit O; Chen C; Bailey-Iacona R; Helterbrand J; Williams G;
Eur J Cancer; 2011 Aug; 47(12):1763-71. PubMed ID: 21435858
[TBL] [Abstract][Full Text] [Related]
20. Phase II trials powered to detect tumor subtypes.
Roberts JD; Ramakrishnan V
Clin Cancer Res; 2011 Sep; 17(17):5538-45. PubMed ID: 21737510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]